Literature DB >> 10759476

Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.

N Tagawa1, J Tamanaka, A Fujinami, Y Kobayashi, T Takano, S Fukata, K Kuma, H Tada, N Amino.   

Abstract

BACKGROUND: Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA-S) have been suggested to have protective effects against cardiovascular disease, cancer, immune-modulated diseases, and aging. We examined serum concentrations of DHEA, DHEA-S, and pregnenolone sulfate (PREG-S) in patients with thyroid dysfunction.
METHODS: Steroids extracted with methanol from serum sample were separated into an unconjugated fraction (DHEA) and a monosulfate fraction (DHEA-S and PREG-S), using a solid-phase extraction and an ion-exchange column. After separation of unconjugated steroids by HPLC, the DHEA concentration was measured by enzyme immunoassay. The monosulfate fraction was treated with arylsulfatase, and the freed steroids were separated by HPLC. The DHEA and PREG fractions were determined by gas chromatography-mass spectrometry, and the concentrations were converted into those of DHEA-S and PREG-S.
RESULTS: Serum concentrations of DHEA, DHEA-S, and PREG-S were all significantly lower in patients with hypothyroidism (n = 24) than in age- and sex-matched healthy controls (n = 43). By contrast, in patients with hyperthyroidism (n = 22), serum DHEA-S and PREG-S concentrations were significantly higher, but the serum DHEA concentration was within the reference interval. Serum concentrations of these three steroids correlated with serum concentrations of thyroid hormones in these patients. Serum albumin and sex hormone-binding globulin concentrations were not related to these changes in the concentration of steroids.
CONCLUSIONS: Serum concentrations of DHEA, DHEA-S, and PREG-S were decreased in hypothyroidism, whereas serum DHEA-S and PREG-S concentrations were increased but DHEA was normal in hyperthyroidism. Thyroid hormone may stimulate the synthesis of these steroids, and DHEA sulfotransferase might be increased in hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759476

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration.

Authors:  Lei Zhao; Guojun Chen; Jun Li; Yingmei Fu; Timur A Mavlyutov; Annie Yao; Robert W Nickells; Shaoqin Gong; Lian-Wang Guo
Journal:  J Control Release       Date:  2017-01-04       Impact factor: 9.776

2.  Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

Authors:  Ozlem Gursoy Calan; Pinar Akan; Aysenur Cataler; Cumhur Dogan; Semra Kocturk
Journal:  Neurochem Res       Date:  2016-03-26       Impact factor: 3.996

Review 3.  Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

4.  Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channels.

Authors:  Y Majeed; A K Agarwal; J Naylor; V A L Seymour; S Jiang; K Muraki; C W G Fishwick; D J Beech
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

5.  Adrenocortical reserves in hyperthyroidism.

Authors:  Kemal Agbaht; Sevim Gullu
Journal:  Endocrine       Date:  2013-03-27       Impact factor: 3.633

6.  TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan.

Authors:  Coziana Ciurtin; Yasser Majeed; Jacqueline Naylor; Piruthivi Sukumar; Anne A English; Paul Emery; David J Beech
Journal:  BMC Musculoskelet Disord       Date:  2010-06-04       Impact factor: 2.362

7.  Discovering oxysterols in plasma: a window on the metabolome.

Authors:  William J Griffiths; Martin Hornshaw; Gary Woffendin; Sharon F Baker; Andrew Lockhart; Sibylle Heidelberger; Magnus Gustafsson; Jan Sjövall; Yuqin Wang
Journal:  J Proteome Res       Date:  2008-07-08       Impact factor: 4.466

8.  Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.

Authors:  Jacqueline Naylor; Jing Li; Carol J Milligan; Fanning Zeng; Piruthivi Sukumar; Bing Hou; Alicia Sedo; Nadira Yuldasheva; Yasser Majeed; Dhananjay Beri; Shan Jiang; Victoria A L Seymour; Lynn McKeown; Bhaskar Kumar; Christian Harteneck; David O'Regan; Stephen B Wheatcroft; Mark T Kearney; Clare Jones; Karen E Porter; David J Beech
Journal:  Circ Res       Date:  2010-04-01       Impact factor: 17.367

9.  The Effects of Elaeagnus angustifolia L. on the Thyroid-Stimulating Hormone, Dehydroepiandrosterone-Sulfate, Prolactin and Cortisol Levels in Post-Menopausal Women: A Double-Blind, Randomized, and Placebo-Controlled Study.

Authors:  Fatemeh Jalalvand; Arezou Rezaei; Bita Badehnoosh; Mehdi Yaseri; Mostafa Qorbani; Farzaneh Emaminia; Mahzad Shabani
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

10.  Pregnenolone sulfate potentiates the inwardly rectifying K channel Kir2.3.

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.